The 4E-BPs are negative regulators of eIF4E (Figure 1) that are inactivated by mTORc1 phosphorylation; the knock-in of 4E-BP phosphomutants reduces the tumor burden [52]. The gene discussed is EIF4E; the disease is neoplasm.